Search

everythinglearnresearchcommunity

for

Search:↓

Living near more dermatologists and using certain cancer screening tests lowers the chance of being diagnosed with advanced skin cancer.

The number of new cases of cutaneous B-cell lymphoma has leveled off since the early 2000s, and survival rates have improved since 1973.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

Denosumab treatment for osteoporosis can cause hair loss.

This special edition focuses on the unique aspects of treating skin conditions in women, including during pregnancy and in diverse populations like women of color and transgender patients.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Some treatments work for common baldness, but there's less evidence for other hair loss types, and more research is needed.

Alopecia areata can cause unpredictable hair loss, and treatments like corticosteroids and minoxidil may help but have varying side effects.

Anti-TNF therapy can cause a unique type of hair loss that may get better with topical treatments without stopping the therapy.

Current treatments for alopecia show no significant long-term benefits.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

A patient lost all their hair while on rheumatoid arthritis medication.

Gray hair can potentially be reversed, leading to new treatments.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Adalimumab was safe but mostly ineffective for severe alopecia areata.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Some medications for inflammation can cause a condition with scalp rashes and hair loss, often linked to Crohn's disease, and may require treatment changes to prevent permanent hair loss.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

A man's gray hair got darker and thicker after using a psoriasis drug.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.